Government Approves Plan to Procure Evusheld for Vulnerable People


The government plans to procure a long-acting antibody drug for people with conditions that prevent them from getting vaccinated against COVID-19.

According to Government Spokesperson Thanakorn Wangboonkongchana, the Center for COVID-19 Situation Administration (CCSA) has approved a plan to procure Evusheld, a long-acting monoclonal antibody designed to prevent COVID transmissions, specifically for individuals with poor immune systems who cannot get vaccinated. 

Evusheld was developed by AstraZeneca using a combination of two long-acting antibodies, tixagevimab and cilgavimab, which work by binding to the spike protein on the outside of the SARS-CoV-2 virus, preventing it from attaching to and entering human cells. It is administered in two injections and provides protection for at least six months.

The government is currently exploring options for obtaining Evusheld, including renegotiating with AstraZeneca to replace some vaccine doses with Evusheld in order to reduce additional payments.

Editorial Staff
Author: Editorial Staff

Provider of news and content to Heaven is Hua Hin

Editorial Staff
Editorial Staff
Provider of news and content to Heaven is Hua Hin


Please enter your comment!
Please enter your name here

Share post:




More like this

Thailand Ranks 8th Globally in English Proficiency, Says EF Index

In the latest edition of the EF English Proficiency...

Illegal Drug Raids Unveil Underground Pharmacy Network

In a recent development, Deputy Public Health Doctor of...

Chonburi’s Culinary Showcase: Amazing Seafood Festival 2023 Thrives

In a bid to reinvigorate the local economy and...

Phuket Launches ‘Phuket Crime Free’ Scheme to Boost Tourist Safety

In a proactive step to enhance the safety of...